Cys-regulation: oxidized CHK1 controls cross-compartment circuit of chemoresistance
1Department of Metabolism and Physiology, Moffitt Cancer Center, Tampa, FL, USA.
Abstract:
In a recent study published in Cell, Zhang et al. integrate genome-wide CRISPRi screening with cysteine chemoproteomics to identify functionally relevant oxidation events associated with the cellular response to chemotherapy. This work uncovered checkpoint kinase 1 (CHK1) as a nuclear reactive oxygen species (ROS) sensor that mediates chemoresistance through the suppression of mitochondrial protein synthesis.
Insights
Researchers discovered that checkpoint kinase 1 (CHK1) acts as a nuclear sensor for reactive oxygen species (ROS), impacting chemotherapy resistance by inhibiting mitochondrial protein synthesis.
Area of Science:
- Cellular biology
- Molecular oncology
- Biochemistry
Background:
- Chemotherapy resistance is a major challenge in cancer treatment.
- Oxidative stress and reactive oxygen species (ROS) play complex roles in cellular responses to therapy.
- Understanding the molecular mechanisms of chemoresistance is crucial for developing effective cancer treatments.
Purpose of the Study:
- To identify novel oxidation events involved in the cellular response to chemotherapy.
- To elucidate the role of reactive oxygen species (ROS) in mediating chemoresistance.
- To uncover the molecular players linking ROS signaling to chemotherapy outcomes.
Main Methods:
- Genome-wide CRISPR interference (CRISPRi) screening was employed to systematically disrupt gene function.
- Cysteine chemoproteomics was utilized to profile oxidation events on proteins.
- Integration of screening and chemoproteomics data to identify functionally relevant oxidation events.
Main Results:
- The study identified checkpoint kinase 1 (CHK1) as a key mediator of chemoresistance.
- CHK1 was characterized as a nuclear sensor of reactive oxygen species (ROS).
- CHK1 suppresses mitochondrial protein synthesis, contributing to chemoresistance.
Conclusions:
- Checkpoint kinase 1 (CHK1) functions as a nuclear ROS sensor in the context of chemotherapy.
- Inhibition of mitochondrial protein synthesis by CHK1 is a mechanism underlying chemoresistance.
- These findings offer potential therapeutic targets for overcoming chemotherapy resistance.
Related Concept Videos
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
Positive Regulator Molecules
Anaphase Promoting Complex
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Crossing Over


